MacroGenics, Inc. (MGNX) financial statements (2021 and earlier)

Company profile

Business Address 9704 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 220305277196158
Cash and cash equivalents 22021284196158
Short-term investments  93193  
Receivables 3014313
Prepaid expense 63324
Other undisclosed current assets 1301143 
Total current assets: 269322284342165
Noncurrent Assets
Property, plant and equipment 575018157
Long-term investments and receivables   8  
Long-term investments   8  
Other noncurrent assets 62122
Other undisclosed noncurrent assets     0
Total noncurrent assets: 635227179
TOTAL ASSETS: 332374311359174
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 3741201510
Accounts payable 42432
Accrued liabilities 333916128
Deferred rent credit 1
Restructuring reserve  0222
Deferred revenue and credits86614
Other liabilities 00 12
Other undisclosed current liabilities 22    
Total current liabilities: 6050272327
Noncurrent Liabilities
Liabilities, other than long-term debt 1025152326
Deferred revenue and credits25152019
Deferred rent credit 10
Restructuring reserve   036
Other undisclosed noncurrent liabilities 19    
Total noncurrent liabilities: 2925152326
Total liabilities: 8975434653
Stockholders' equity
Stockholders' equity attributable to parent 243299269313121
Common stock 00000
Treasury stock, value     (0)
Additional paid in capital 733611561547335
Accumulated other comprehensive loss (0)(0)(0)(0) 
Accumulated deficit (490)(312)(293)(234)(214)
Total stockholders' equity: 243299269313121
TOTAL LIABILITIES AND EQUITY: 332374311359174

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net1589210148
Gross profit: 601589210148
Operating expenses (231)(180)(152)(121)(86)
Operating loss: (171)(22)(60)(20)(38)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
 (0)3200
Net loss available to common stockholders, diluted: (171)(20)(59)(20)(38)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (171)(20)(59)(20)(38)
Comprehensive loss, net of tax, attributable to parent: (171)(20)(59)(20)(38)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: